Fixing the skin barrier: Past, present and future - man and dog compared

Veterinary Dermatology

Volumn 24, Issue 1, 2013, Pages

  Marsella, Rosanna ^a  

^a University of Florida College of Veterinary Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN; EMOLLIENT AGENT; GLUCOCORTICOID; HYGROSCOPIC AGENT; WATER;

ANIMAL; ANIMAL DISEASE; ARTICLE; DOG; DRUG ANTAGONISM; DRUG EFFECT; FUNCTIONS OF THE SKIN AND ITS APPENDAGES; HUMAN; METABOLISM; METHODOLOGY; SKIN ABSORPTION; SKIN CARE; SKIN DISEASE; THERMOREGULATION; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ANIMALS; CALCINEURIN; DOGS; EMOLLIENTS; GLUCOCORTICOIDS; HUMANS; HYGROSCOPIC AGENTS; SKIN ABSORPTION; SKIN CARE; SKIN DISEASES; SKIN PHYSIOLOGICAL PHENOMENA; WATER; WATER LOSS, INSENSIBLE;

CANIS FAMILIARIS;

EID: 84872689688     PISSN: 09594493     EISSN: 13653164     Source Type: Journal    
DOI: 10.1111/j.1365-3164.2012.01073.x     Document Type: Article

References (54)

1. Aalto-Korte K. Improvement of skin barrier function during treatment of atopic dermatitis. J Am Acad Dermatol 1995; 33: 969-972.
2. Lodén M. Role of topical emollients and moisturizers in the treatment of dry skin barrier disorders. Am J Clin Dermatol 2003; 4: 771-788.
3. Wirén K, Nohlgård C, Nyberg F et al. Treatment with a barrier-strengthening moisturizing cream delays relapse of atopic dermatitis: a prospective and randomized controlled clinical trial. J Eur Acad Dermatol Venereol 2009; 23: 1267-1272.
4. Simpson EL, Berry TM, Brown PA et al. A pilot study of emollient therapy for the primary prevention of atopic dermatitis. J Am Acad Dermatol 2010; 63: 587-593.
5. Tsai TF, Maibach HI. How irritant is water? An overview. Contact Dermatitis 1999; 41: 311-314.
6. Rendell ME, Baig-Lewis SF, Berry TM et al. Do early skin care practices alter the risk of atopic dermatitis? A case-control study. Pediatr Dermatol 2011; 28: 593-595.
7. Simpson EL. Atopic dermatitis: a review of topical treatment options. Curr Med Res Opin 2010; 26: 633-640.
8. Matsumoto T, Yuasa H, Kai R et al. Skin capacitance in normal and atopic infants, and effects of moisturizers on atopic skin. J Dermatol 2007; 34: 447-450.
9. Patzelt A, Lademann J, Richter H et al. In vivo investigations on the penetration of various oils and their influence on the skin barrier. Skin Res Technol 2012; 18: 364-369.
10. Buraczewska I, Berne B, Lindberg M et al. Changes in skin barrier function following long-term treatment with moisturizers, a randomized controlled trial. Br J Dermatol 2007; 156: 492-498.
11. Buraczewska I, Berne B, Lindberg M et al. Long-term treatment with moisturizers affects the mRNA levels of genes involved in keratinocyte differentiation and desquamation. Arch Dermatol Res 2009; 301: 175-181.
12. Puschmann M, Gogoll K. Improvement of skin moisture and skin texture with urea therapy. Hautarzt 1989; 40(Suppl 9): 67-70.
13. Amichai B, Grunwald MH. A randomized, double-blind, placebo-controlled study to evaluate the efficacy in AD of liquid soap containing 12% ammonium lactate + 20% urea. Clin Exp Dermatol 2009; 34: e602-e604.
14. Lodén M, Andersson AC, Lindberg M. Improvement in skin barrier function in patients with atopic dermatitis after treatment with a moisturizing cream (Canoderm). Br J Dermatol 1999; 140: 264-267.
15. Grether-Beck S, Felsner I, Brenden H et al. Urea uptake enhances barrier function and antimicrobial defense in humans by regulating epidermal gene expression. J Invest Dermatol 2012; 132: 1561-1572.
16. Madaan A. Epiceram for the treatment of atopic dermatitis. Drugs Today (Barc) 2008; 44: 751-755.
17. Bikowski J. Case studies assessing a new skin barrier repair cream (epiceram) for the treatment of atopic dermatitis. Drugs Dermatol 2009; 8: 1037-1041.
18. Kircik LH, Del Rosso JQ. Nonsteroidal treatment of atopic dermatitis in pediatric patients with a ceramide-dominant topical emulsion formulated with an optimized ratio of physiological lipids. J Clin Aesthet Dermatol 2011; 4: 25-31.
19. Sugarman JL, Parish LC. Efficacy of a lipid-based barrier repair formulation in moderate-to-severe pediatric atopic dermatitis. J Drugs Dermatol 2009; 8: 1106-1111.
20. Veraldi S, De Micheli P, Schianchi R et al. Treatment of pruritus in mild-to-moderate atopic dermatitis with a topical non-steroidal agent. J Drugs Dermatol 2009; 8: 537-539.
21. Akasaka Y, Yoshida T, Tsukahara M et al. Glycyrrhetinic acid prevents cutaneous scratching behavior in mice elicited by substanceP or PAR-2 agonist. Eur J Pharmacol 2011; 670: 175-179.
22. Lee SE, Jeong SK, Lee SH. Protease and protease-activated receptor-2 signaling in the pathogenesis of atopic dermatitis. Yonsei Med J 2010; 51: 808-822.
23. Steinhoff M, Neisius U, Ikoma A et al. Proteinase-activated receptor-2 mediates itch: a novel pathway for pruritus in human skin. J Neurosci 2003; 23: 6176-6680.
24. Asl MN, Hosseinzadeh H. Review of pharmacological effects of Glycyrrhiza sp. and its bioactive compounds. Phytother Res 2008; 22: 709-724.
25. Miller DW, Koch SB, Yentzer BA et al. An over-the-counter moisturizer is as clinically effective as, and more cost-effective than, prescription barrier creams in the treatment of children with mild-to-moderate atopic dermatitis: a randomized, controlled trial. J Drugs Dermatol 2011; 10: 531-537.
26. Jensen JM, Pfeiffer S, Witt M et al. Different effects of pimecrolimus and betamethasone on the skin barrier in patients with atopic dermatitis. J Allergy Clin Immunol 2009; 123: 1124-1133.
27. Grzanka A, Zebracka-Gala J, Rachowska R et al. The effect of pimecrolimus on expression of genes associated with skin barrier dysfunction in atopic dermatitis skin lesions. Exp Dermatol 2012; 21: 184-188.
28. Kim M, Jung M, Hong SP et al. Topical calcineurin inhibitors compromise stratum corneum integrity, epidermal permeability and antimicrobial barrier function. Exp Dermatol 2010; 19: 501-510.
29. Marsella R, Olivry T, Carlotti DN et al. Current evidence of skin barrier dysfunction in human and canine atopic dermatitis. Vet Dermatol 2011; 22: 239-248.
30. Olivry T. Is the skin barrier abnormal in dogs with atopic dermatitis? Vet Immunol Immunopathol 2011; 144: 11-16.
31. Olivry T, Wofford J, Paps JS et al. Stratum corneum removal facilitates experimental sensitization to mite allergens in atopic dogs. Vet Dermatol 2011; 22: 188-196.
32. Yoon JS, Nishifuji K, Sasaki A et al. Alteration of stratum corneum ceramide profiles in spontaneous canine model of atopic dermatitis. Exp Dermatol 2011; 20: 732-736.
33. Reiter LV, Torres SM, Wertz PW. Characterization and quantification of ceramides in the nonlesional skin of canine patients with atopic dermatitis compared with controls. Vet Dermatol 2009; 20: 260-266.
34. Inman AO, Olivry T, Dunston SM et al. Electron microscopic observations of stratum corneum intercellular lipids in normal and atopic dogs. Vet Pathol 2001; 38: 720-723.
35. Marsella R, Samuelson D, Doerr K. Transmission electron microscopy studies in an experimental model of canine atopic dermatitis. Vet Dermatol 2010; 21: 81-88.
36. Popa I, Remoue N, Hoang LT et al. Atopic dermatitis in dogs is associated with a high heterogeneity in the distribution of protein-bound lipids within the stratum corneum. Arch Dermatol Res 2011; 303: 433-440.
37. Bäumer W, Rossbach K, Mischke R et al. Decreased concentration and enhanced metabolism of sphingosine-1-phosphate in lesional skin of dogs with atopic dermatitis: disturbed sphingosine-1-phosphate homeostasis in atopic dermatitis. J Invest Dermatol 2011; 131: 266-268.
38. Lau-Gillard PJ, Hill PB, Chesney CJ et al. Evaluation of a hand-held evaporimeter (VapoMeter) for the measurement of transepidermal water loss in healthy dogs. Vet Dermatol 2010; 21: 136-145.
39. Shimada K, Yoon JS, Yoshihara T et al. Increased transepidermal water loss and decreased ceramide content in lesional and non-lesional skin of dogs with atopic dermatitis. Vet Dermatol 2009; 20: 541-546.
40. Marsella R. Are transepidermal water loss and clinical signs correlated in canine atopic dermatitis: a compilation of studies. Vet Dermatol 2012; 23: 238-e49.
41. Piekutowska A, Pin D, Rème CA et al. Effects of a topically applied preparation of epidermal lipids on the stratum corneum barrier of atopic dogs. J Comp Pathol 2008; 138: 197-203.
42. Popa I, Remoue N, Osta B et al. The lipid alterations in the stratum corneum of dogs with atopic dermatitis are alleviated by topical application of a sphingolipid-containing emulsion. Clin Exp Dermatol 2012; 37: 665-671.
43. Fujimura M, Nakatsuji Y, Fujiwara S et al. Spot-on skin lipid complex as an adjunct therapy in dogs with atopic dermatitis: an open pilot study. Vet Med Int 2011; 2011: 281846.
44. ®) on clinical signs and skin barrier function in dogs with atopic dermatitis: a double blinded, randomized, controlled study. Vet Dermatol 2012; 23: (Suppl 1): (abstract).
45. Tretter S, Mueller RS. The influence of topical unsaturated fatty acids and essential oils on normal and atopic dogs. J Am Anim Hosp Assoc 2011; 47: 236-240.
46. Popa I, Pin D, Remoué N et al. Analysis of epidermal lipids in normal and atopic dogs, before and after administration of an oral omega-6/omega-3 fatty acid feed supplement. A pilot study. Vet Res Commun 2011; 35: 501-509.
47. Bourdeau P, Bruet V, Gremillet C. Evaluation of phytosphingosine-containing shampoo and microemulsion spray in the clinical control of allergic dermatoses in dogs: preliminary results of a multicentre study. Vet Dermatol 2007; 18: 177-178.
48. Mao-Qiang M, Brown BE, Wu-Pong S et al. Exogenous nonphysiologic vs physiologic lipids: divergent mechanisms for correction of permeability barrier dysfunction. Arch Dermatol 1995; 131: 809-816.
49. Ghadially R, Halkier-Sorensen L, Elias PM. Effects of petrolatum on stratum corneum structure and function. J Am Acad Dermatol 1992; 26: 387-396.
50. Federal Register. Skin protectant drug products for over-the-counter human use. 1983: Part 347: 48: 6832.
51. Pellicoro C, Marsella R, Ahrens K. Evaluation of the clinical and skin barrier effects of topical therapy with dimethicone in dogs with naturally occurring atopic dermatitis. Vet Dermatol 2011; 22: 291.
52. Ohmori K, Tanaka A, Makita Y et al. Pilot evaluation of the efficacy of shampoo treatment with ultrapure soft water for canine pruritus. Vet Dermatol 2010; 21: 477-483.
53. Feldt D, Marsella R, Ahrens K. A prospective, blinded, controlled pilot study to evaluate the effects of cyclosporine (Atopica) on skin barrier function in canine atopic dermatitis by measurement of trans-epidermal water loss. Accepted abstract at World congress.
54. Cornegliani L, Vercelli A, Sala E et al. Transepidermal water loss in healthy and atopic dogs, treated and untreated: a comparative preliminary study. Vet Dermatol 2012; 23: 41-44.